Navigation Links
Safety Of Dental Amalgam Fillings To Be Reviewed

The Food and Drug administration (FDA) has asked a panel of outside experts to review the safety of dental amalgam fillings due to the persistent complaints that the fillings may cause health problems.//

The U.S. health officials found no evidence to suggest that the fillings were dangerous in dozen of studies conducted to review the safety of mercury in the silver fillings, and the FDA has asked the panel of outside experts to look into the matter to see if they agree with the findings or think there is reason for worry.

The silver fillings made with mercury is used to fill cavities in teeth in tens of millions of Americans each year as it is durable, easy to use, and relatively inexpensive when compared to tooth-colored fillings.

However, mercury is known to be toxic to brain and kidneys and because of this some consumers feel the use of mercury in dentistry is not warranted as there are other fillings available and are planning to file a petition asking the FDA to immediately ban them for pregnant women.

Charles Brown, Counsel for Consumers for Dental Choice, said if the FDA does not act, "we are going to still continue to use it in pregnant women and children even though we know mercury causes brain damage. It's morally and legally unacceptable."

Silver fillings along with fish consumption and vaccines has been listed as the major sources of mercury exposure in the United States by the FDA. However, health officials say that the mercury vapors emitted from fillings are too small to cause harm.

In a draft report prepared for the advisory panel meeting, the FDA said it has found no evidence to suggest that use of mercury in fillings is harmful. The agency said, "The weight of evidence does not support the hypothesis that exposure to mercury via dental amalgam restorations causes adverse biological outcomes."
SAR
'"/>




Page: 1

Related medicine news :

1. New standards for Human Research Safety
2. Safety of soy under suspicion
3. The Safety Of Prenatal Ultrasounds Questioned
4. Report on the Safety and Effectiveness of Melatonin supplements
5. Monitoring Drug Safety
6. Safety Of Indian Sex Workers At Risk Due To Poor Condom Usage
7. Safety Of Heart Drug Questioned
8. Race Was Used To Determine Safety Of Blood
9. Patient Safety Forces Closure Of Hospital
10. Farm Boy Airlifted by PSNI helicopter To Safety
11. Strict Safety Measures On Import of Poultry From China
Post Your Comments:
(Date:7/18/2008)...d Mexican Cuisine are Featured at East LA Meets Na... Services Corporation, LOS ANGELES, July 18 /PRNe...d annual East LA Meets Napa celebration featuring ... wine makers and 20 Los Angeles area Mexican,resta...wine and culinary,enthusiasts who enjoyed great mu...
(Date:7/18/2008)...on the wagon an antidepressant restored brain,s ab... 18 (HealthDay News) -- Giving up your few drinks ...ion, a new study says. , "Our research in an an...nence from alcohol drinking and depression," study...hiatry and pharmacology in the University of North...
(Date:7/18/2008)...t weight loss yields significant health benefits, ...lition -- a group of,experts on overweight and obe...a to reevaluate the way they report on weight loss... news coverage and editorial content that,leads co...ieters if they,lose an enormous amount of weight, ...
(Date:7/18/2008)...Is Not What America Signed Up For, WASHINGTON, Ju...cCain,s,top economic advisor, Phil Gramm, echoed M...were "psychological" by saying Americans are in a ...nation of whiners." While McCain,distanced himself...d as,McCain,s top economic adviser. Now, John McCa...
Breaking Medicine News(10 mins):Health News:Move Over Margarita! Mexican Food has a New Dinner Partner 2Health News:Move Over Margarita! Mexican Food has a New Dinner Partner 3Health News:Research Finds Causal Link Between Ending Drinking, Depression 2Health News:Medical Experts Call on Media to Rethink Coverage of Weight Loss 2Health News:Medical Experts Call on Media to Rethink Coverage of Weight Loss 3Health News:DNC: McCain Watch: The Economy 2Health News:DNC: McCain Watch: The Economy 3
...us University Hospital, Denmark, in a first of its...with a group of ankle injury patients. They found ... in the neck, head, shoulder, arm and even lower b...y of the two groups, pain in the ankle injury grou...
... toenails is a problem that occurs in 1 in 2 perso...y a long standing fungal infection and it gives to...tors at the Mayo Clinic advice consulting with a c...ug. However, these drugs might cause some side eff...
...s Chairman, Tajendra Khanna, in a recent seminar o...ity on 'Managing Corporate Reputation', spoke abou...rugs market. He said that their products would cre...market - Dabur, which has 60 per cent market share...
...r ectopy, another name for premature heart beat, d...searchers to be a better predictor of an increased.... Doctors from Cleveland Clinic Foundation observe...re, valve disease or arrhythmia. They were referre...
Other Medicine News:
(Date:7/16/2008)...orts Pivotal Phase 2b Clinical Trials of First, ...f Cystic Fibrosis -, SOUTH PLAINFIELD, N.J. and B...tics, Inc. (PTC) and Cystic Fibrosis Foundation Th...f the Cystic Fibrosis Foundation, today,announced ...ort development,of PTC124, the PTC,s new investiga...
(Date:7/16/2008)...ly 16 /- MAP,Pharmaceutical...ve results,from a Phase 2 study evaluating the saf...in adult asthmatics were published in the July,iss...armaceuticals is,developing MAP0004, an orally inh... treatment for migraine., The study results, whic...
(Date:7/15/2008)...ewswire/ -- Abeome Corporation, a,Georgia-based bi...investment by Cato BioVentures and a collaboration...arch and development organization. The investment,...lopment of Abeome,s lead,ovarian cancer project., ...he development of,monoclonal antibodies and Abeome...
(Date:7/15/2008)...of Phase III Trials of Light Infusion Therapy,in H...Cancer and Phase I/II and Phase IIa Beni..., July 15 /- Light Sciences Oncology,...ight Infusion Therapy(TM),(Litx(TM)) to treat canc...as raised $40.1 million in a Series C round of fin...
Breaking Medicine Technology:PTC Therapeutics Announces $25 Million Award From Cystic Fibrosis Foundation Therapeutics for Development of PTC124 2PTC Therapeutics Announces $25 Million Award From Cystic Fibrosis Foundation Therapeutics for Development of PTC124 3PTC Therapeutics Announces $25 Million Award From Cystic Fibrosis Foundation Therapeutics for Development of PTC124 4MAP Pharmaceuticals Announces Publication of MAP0004 Study in Current Medical Research and Opinion 2MAP Pharmaceuticals Announces Publication of MAP0004 Study in Current Medical Research and Opinion 3MAP Pharmaceuticals Announces Publication of MAP0004 Study in Current Medical Research and Opinion 4Abeome and Cato Research to Collaborate on Ovarian Cancer Therapeutic 2Light Sciences Oncology Raises $40.1 Million in Series C Financing 2WuXi PharmaTech Completes Acquisition of AppTec 2919 1WuXi PharmaTech Completes Acquisition of AppTec 2919 2Survey 3A Massachusetts Employers Employees Paying Most for Health Care Plans 10689 1Survey 3A Massachusetts Employers Employees Paying Most for Health Care Plans 10689 2Survey 3A Massachusetts Employers Employees Paying Most for Health Care Plans 10689 3DURECT Corporation Invites You to Join Its Fourth Quarter 2007 Earnings Conference Call 2917 1MITs McGovern Institute researchers awarded 248 5M to study brain basis of autism and dyslexia 10682 1MITs McGovern Institute researchers awarded 248 5M to study brain basis of autism and dyslexia 10682 2
...ENCE, Italy - 8 March 2007 - Cancer drug,developer...unces,positive initial findings from its second, c...cell lung cancer. , This 30-patient trial tested a...rboplatin and paclitaxel chemotherapy.,Investigato...of,patients showed disease stabilisation, while on...
...evelopment program of first-in-class CB1,antagonis...ion and,avoid image as life-style drug , BARCELONA...ce,firm La Merie S.L. reported today that Sanofi-A...ia (rimonabant) has at least,five competitors in c...rlier phases of R&D. While Acomplia received E...
Other Medicine Technology:Antisoma plc (UK) - Second lung cancer trial adds to positive data,on AS1404 2Antisoma plc (UK) - Second lung cancer trial adds to positive data,on AS1404 3Weight Management is Not Enough for Cannabinoid Type 1 (CB1),Receptor Antagonists to Become a Commercial Success 2Weight Management is Not Enough for Cannabinoid Type 1 (CB1),Receptor Antagonists to Become a Commercial Success 3
A variety of surgical drapes that provide a vertical barrier to keep the C-arm isolated from the sterile surgical field during hip/femur fracture or trauma procedures. Available with pouches and with
...ll-in-one procedure drape made of 3M™ Steri-...elastic aperture, to create a sterile field during...ake draping quick and convenient by eliminating th...remity drapes with elastic apertures suitable for ...
...OCT, which includes bed side and near patient test...osed unique problems for hospitals and clinical la...sibility to decentralized areas focused on patient... the problem is the reality of controlling staffin...
The Abbott Commander is an automated, high-throughput immunoassay testing system. The Commander System consists of the Flexible Pipetting Center, the Parallel Processing Center, and the Dynamic Incub
Medicine Products: